AUTHORS

Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at http://www.bretjenseninvests.com. Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

Stocks to Buy Into a Year-End Rally

The likelihood of a seasonal rally is rising -- here is how to play it.

Here's Why Homebuilders Are Getting a Lift

I still like some of the names in this sector to rally further off oversold levels.

2 Small Biotech Stocks That Insiders Are Buying

Both names looked poised to go higher as soon as sentiment around the small biotech sector improves.

The Market Is Cheaper Than in Years, and Beaten-Down Sectors May Be Bottoming

The S&P 500 began the year selling at 18.2x forward earnings. It is now at around 15x projected earnings.

3 Black Friday Bargains: Olin, Entercom and Energy Transfer

These stocks are deep in bargain territory.

One Way to Face Market Fears Is With a Facebook Options Play

Alarmist headlines about Facebook aside, the social media juggernaut still offers an avenue to make money.

Here's a Handful of Ways to Navigate Biotech's Choppy Seas

Biotech ETFs could mitigate risk amid the sector's volatility, and names such as Exelixis, ANI Pharmaceuticals and Progenics hold promise.

Here's How I'm Playing Biotech Now

I continue to deploy 'dry powder' into the biotech sector on dips using Buy-Write option strategies.

Beazer's Big Jump Builds Case for My Contrarian View on Sagging Housing Stocks

The homebuilder shot up 30% on Tuesday after crushing earnings expectations and likely won't be the only bet to pay off in the sector.

In This Divergent Market, Focus on Pockets of Strength

Expect continued volatility in the near-term, but clearer skies are coming. Meantime, some names and sectors offer buying opportunities.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight